TherapeuticsMD Inc (TXMD) reported quarterly earnings results on Thursday, Aug-4-2016. The company reported $-0.11 earnings per share for the quarter, missing the analyst consensus estimate by $-0.01. Analysts had a consensus of $-0.10. The company posted revenue of $4.40 million in the period, compared to analysts expectations of $5.63 million. The company’s revenue was down -8.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.16 EPS.
TherapeuticsMD Inc closed down -0.06 points or -0.77% at $7.71 with 6,62,521 shares getting traded on Tusday. Post opening the session at $7.81, the shares hit an intraday low of $7.6 and an intraday high of $7.83 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
In a different news, on Mar 14, 2016, Cooper C. Collins (director) purchased 16,000 shares at $6.23 per share price. According to the SEC, on Aug 27, 2015, Angus C. Russell (director) purchased 13,500 shares at $5.98 per share price. On Aug 24, 2015, Tommy G Thompson (director) purchased 10,798 shares at $6.29 per share price, according to the Form-4 filing with the securities and exchange commission.
TherapeuticsMD Inc. is a women’s health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. It manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter (OTC) vitamins. It markets its prescription and OTC prenatal vitamins and other products under its vitaMedMD brand name and duplicate formulations of its prescription prenatal vitamin products also referred to as generic formulations under its BocaGreenMD brand name. The Company’s products include prenatal vitamins vitaMedMD Plus Rx vitaMedMD One Rx vitaMedMD RediChew Rx and BocaGreenMD Prena1 line of prescription prenatal vitamins which included three prescription prenatal vitamins that were generic formulations of its vitaMedMD-branded prescription prenatal vitamins.